Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05860907 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis

StatusNot Yet Recruiting
PhasePhase 4
Started2023-10
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 26, 2023 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2023-09-22
Study Status, Study Description, Study Design, Arms and Interventions v1
Start date2023-05→2023-10
Enrollment target341→384
Study description-1 characters
This study used a blank control design and included at least 341384 subjects. The experimental group and control group were randomized in a 2:1 ratio (at least 228256 subjects in the experimental group and at least 113128 subjects in the control group). Patients in the experimental group were treated with Huai ErHuaier Granules (20g10g/dose, 3 times/day), while undergoing routine diagnosis and [...]
2023-05-12
Original filing
Fudan University
624 trials monitored
See 9 trials at risk
Breast Cancer
5,180 trials monitored
See 256 trials at risk
This is a multicenter, open-label, randomized controlled, prospective clinical study to evaluate the efficacy and safety of Huaier Granules in patients with advanced breast cancer without visceral metastasis.
Trial Details
NCT Number NCT05860907
Lead Sponsor Fudan University
Collaborators: LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Conditions Breast Cancer Stage IV
Enrollment 384 participants
Start Date 2023-10
Primary Completion 2025-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2023-09-26